The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.
FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.
This week, we will be coming to you LIVE! Wednesday, June 24, 2020 7 PM EDT/ 4 PM PDT
EVOLVING CONCEPTS IN DERMATOLOGY PART VIII
JAK Inhibitors on the Horizon: Effective Topical and Oral Treatments for Vitiligo, AD, and AA, Brett A. King, MD, PhD
Diagnostic, Therapeutic, and Management Update: What’s New and Important, Gary Goldenberg, MD
Integrating SRT Into Your Practice, Jeffrey S. Fromowitz, MD
Medical Director & Managing Partner
Dermatology of Boca
Adjunct Clinical Assistant professor
Florida Atlantic University College of Medicine
Boca Raton, FL
Gary Goldenberg, MD
Faculty
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Brett King, MD, PhD
Faculty
Associate Professor of Dermatology
Yale School of Medicine
New Haven, CT
Upon completion of this activity, the participant should be better able to:
Identify an emerging and important class of medications in dermatology
Describe topical and oral JAK inhibitors that are showing promise for the treatment of vitiligo, AD, and AA
Discover the latest data on medications and technologies you are able to use and will be able to use to improve patients’ lives.
Discuss Superficial Radiation Therapy Basics
Review Treatment of Skin Cancer with SRT
Outline how to integrate SRT into your clinical practice
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and the Foundation for Research and Education in Dermatology. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, Lilly, Mayne Pharma, and UCB.
CONFLICTS OF INTEREST/DISCLOSURES
Jeffrey S. Fromowitz, MD
Consultant/Independent Contractor: Bausch Health, Dermavent, Galderma, Pfizer, and Sanofi
Speakers Bureau: Almirall, Bausch Health, Celgene, and Galderma
Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.